Salute e Benessere

Luscii Works with Jamf to Extend Access to Remote Patient Monitoring via iPad to…

Luscii's care at home platform empowers healthcare professionals to remotely monitor patients, allowing for early detection of health deterioration, reducing hospital admissions, and improving patient outcomes. It is already used for over 130 different conditions and 200 care pathways. With the added support of Jamf's device management solution, healthcare providers can ensure that iPads used for remote patient monitoring are securely configured, updated, and managed according to strict…
PR Newswire
12/09/2023

Invitation to Implantica's CMD in Stockholm on September 26, 2023

Among others, the CMD will feature: Among others, the CMD will feature: Furthermore, we will hear from: Registration for the CMD is donehere. Please note that confirmation is required to attend the live event. No pre-registration is required to watch thewebcast. For further information, please contact: Nicole Pehrsson, Chief Corporate Affairs Officer Telephone (CH): +41 (0)79 335 09 49nicole.pehrsson@implantica.com Implantica is listed on Nasdaq First North Premier...
PR Newswire
12/09/2023

Beactica Therapeutics strengthens its preclinical development team

Dr Carl-Magnus Andersson has more than 35 years of experience from drug discovery and development and has held senior positions within a number of pharma and biotech companies, including AstraDraco, Acadia Pharmaceuticals, and KaroBio, where he has been responsible for the chemical and pharmaceutical sciences and also intellectual property strategies. During his career, Dr Andersson has managed the process development and manufacture of a variety of small molecules for clinical trials. He was…
PR Newswire
12/09/2023

Salipro Biotech enters into research collaboration with Sumitomo Pharma to…

The collaboration leverages Salipro Biotech's unique expertise and its Salipro ®platform technology to stabilize a challenging drug target to investigate the pharmacological characteristics of a compound from Sumitomo Pharma's discovery program. STOCKHOLM, Sweden, Sept.12, 2023(GLOBE NEWSWIRE) -- Swedish biotech company Salipro Biotech AB today announced that it has entered into a research collaboration with Sumitomo Pharma Co., Ltd. to reveal the mechanism of action and...
Nasdaq GlobeNewswire
12/09/2023

Inside information: Bioretec enters into the U.S. distribution agreement with…

"Spartan Medical's view on the commercialization of new products in the orthopedic market perfectly aligns with Bioretec's vision for a controlled launch of RemeOs™ screws, which we believe is crucial in ensuring the widespread adoption and success of RemeOs™ screws in the times ahead. The path to choosing the distribution partnership in the United States was diligently assessed. Bioretec considered various options, ranging from collaboration with international industrial players to…
PR Newswire
12/09/2023

Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader…

"While double readings by two radiologists have been established as the common practice across Europe and Australia, many countries are experiencing great difficulties due to the shortage of radiologists," explained Dr. Strand, breast radiologist and associate professor at Karolinska Institutet. "This prospective study lays the groundwork for the widespread adoption of AI in breast cancer screening by filling the role of one radiologist, which in turn can reduce medical costs and…
PR Newswire
12/09/2023

Io Therapeutics, Inc., Announces Publication of Data on a Novel Compound…

Scientific Reports – Nature Publishing Group,of results from studies done with the company's novel anti-cancer compound IRX4647, an agonist of the retinoic acid nuclear receptor gamma, discovered in the company's oncology drug program. The paper, titled “A novel retinoic acid receptor-gamma agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment,” authored by Cheng-Hsin Wei, Ph.D.,et al., reports studies done in the laboratory of the...
Nasdaq GlobeNewswire
12/09/2023

Gates Foundation Goalkeepers Report Says Seven Innovations Could Save 2 Million…

Co-authored by foundation Co-chairs Melinda French Gates and Bill Gates, the report highlights new data that shows the potential of scaling up global access to seven innovations and practices that address the leading causes of maternal and newborn deaths. Co-authored by foundation Co-chairsMelinda French GatesandBill Gates, the report highlights new data that shows the potential of scaling up global access to seven innovations and practices that address the leading causes of maternal and...
PR Newswire
12/09/2023

Foresee Pharmaceuticals Presents Data From its Aderamastat Program at The…

The oral presentation entitled: "Effect of MMP-12 inhibitor, aderamastat (FP-025), on allergen-induced late response in asthmatic subjects" is the result of a collaboration with clinical experts in the area of asthma and pulmonology in the Netherlands and focused on the primary results from the assessment of the efficacy of multiple oral doses of aderamastat in HDM-allergic asthma patients. The oral presentation entitled: "Effect of MMP-12 inhibitor, aderamastat (FP-025), on…
PR Newswire
12/09/2023

Sanofi: Information concerning the total number of voting rights and shares -…

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of theCode de commerce(the French Commercial Code) and article 223-16 of theRèglementgénéral de l'Autorité des Marchés Financiers(Regulation of the French stock market authority) Sanofi a Frenchsociété anonymewith a registered share capital of 2,529,036,828 € Registered office : 46, avenue de la Grande Armée - 75017 Paris - France...
Nasdaq GlobeNewswire
11/09/2023

Attention-Deficit/Hyperactivity Disorder Market to Grow Rapidly by 2032…

Key Takeaways from the Attention-Deficit/Hyperactivity Disorder Market Report Discover which therapies are expected to grab the major attention-deficit/hyperactivity disorder market share @Attention-Deficit/Hyperactivity Disorder Market Report Attention-Deficit/Hyperactivity Disorder Overview Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects both children and adults, though it often manifests during childhood. Its exact...
PR Newswire
11/09/2023

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as…

Disclosure of Share Capital and Voting Rights Outstandingas of August 31 , 2023(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)Charenton-le-Pont, France (September11 , 2023 - 6:00 pm)– As of August 31, 2023, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution...
Nasdaq GlobeNewswire
11/09/2023

Groupe Casino - Nombre de droits de vote et d'actions au 31-08-2023

CASINO, GUICHARD-PERRACHON Société anonyme au capital de 165 892 131,90 € Siège social : 1, Cours Antoine Guichard 42000 Saint-Etienne 554 501 171 R.C.S. Saint-Etienne Informations relatives au nombre total de droits de vote et d'actions composant le capital social au 31 août 2023(article 223-16 du Règlement Général de l'Autorité des Marchés Financiers)Nombre d'actions composant le capitalNombre total de droits de voteNombre total de droits de vote exerçables en...
Nasdaq GlobeNewswire
11/09/2023

Patient Advocacy Organization POIC e dintorni APS and Dante Genomics forge…

The 2nd World Congress of Pediatric Neurogastroenterology and Motility serves as a fitting stage for the partnership's unveiling. This international event gathers leading experts, researchers, and medical professionals in the field to share insights, advancements, and innovations. POIC e dintorni and Dante Genomics will present their collaborative efforts through presentations, interactive sessions, and informational booths, facilitating meaningful discussions and knowledge exchange. The 2nd...
PR Newswire
11/09/2023

Microfluidics Market worth $41.1 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1305 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1305 Browse in-depth TOC on "Microfluidics Market" 300 - Tables 66 - Figures 335 - Pages Microfluidics Market Scope: The microfluidics market is further segmented based on the product, application, end-user, and region. The microfluidic-based devices segment holds the...
PR Newswire
11/09/2023

Exploring the Demodex Blepharitis Market: Clinical Viewpoints, Pipeline…

This devastating ailment is known to affect a significant part of the global population. It predominantly impacts the geriatric individuals aged above 60. According to a data released by NIH, around 41% to 70% of the world's population are affected or highly prone to Demodex Blepharitis. The major factor behind the occurrence of this condition is the overpopulation of Demodex mites on the eyelids. Apart from that, age, weak immune system, poor hygiene, and the presence of certain skin conditions…
PR Newswire
11/09/2023

Lupus Disease Statistics worldwide: Drug Development, Clinical Trials, and…

Key Takeaways: Key Takeaways: Price and Market Access What are the major types of Lupus Disease? There are several types of Lupus Disease with systemic lupus erythematosus (SLE) being the most common one. Each type of Lupus has its own characteristics and symptoms. Here is an overview of the major types of Lupus- Systemic Lupus Erythematosus (SLE)- It is regarded as one of the most commonly occurring forms of Lupus. It majorly affects the skin, joints, kidneys, heart, lungs,...
PR Newswire
11/09/2023

CHARAC RECEIVES £1.2M FUNDING BOOST TO SUPPORT ITS MISSION OF SAVING THE UK'S…

LONDON, Sept. 11, 2023 /PRNewswire/ -- Charac, an NHS-integrated pharmacy app designed to lessen independent community pharmacies' operational burdens and help them deliver on the Government's Pharmacy First approach has raised some £1.2 million in debt and equity financing jointly from the National Pharmacy Association (NPA) and pharmacy owners, bringing total funding to date to £2.5 million. LONDON , Sept. 11, 2023 /PRNewswire/ -- Charac, an NHS-integrated pharmacy app designed to...
PR Newswire
11/09/2023

Revolutionizing Vaccine Discovery: New Data Validates Evaxion AI Platform…

Evaxion is the first organization to validate an AI model that outcompetes state-of-the-art vaccine developmentEvaxion's AI model predicts vaccine efficacy in infectious disease modelsThese results mean using EDEN TMwill allow for a faster, cheaper, and lower-risk vaccine development compared to current approaches COPENHAGEN, Denmark, Sept.11, 2023(GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion" or the "Company"), a clinical-stage biotechnology company...
Nasdaq GlobeNewswire
11/09/2023

MGI Launches the DCS Lab Initiative to Expand Global Omics Access and…

With its name taken from the first letter of MGI's three core technologies, the DCS Lab Initiative is MGI's first initiative targeting international laboratories with focus on frontier science and represents the company's unique capability within the industry in providing end-to-end products for applications ranging from DNA genomics to cell omics and spatial omics. It also aligns with the company's vision to enhance access to omics worldwide for the development of life science and healthcare…
PR Newswire
11/09/2023

Jazz Pharmaceuticals Showcases Impact of Sleep Medicine Portfolio at Psych…

DUBLIN, Sept. 11, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that six abstracts presenting data from across its sleep medicine portfolio were featured at the 36th annual Psych Congress, held September 6-10, 2023. One of the accepted abstracts provided a comprehensive review of clinical data that assessed the impact of oxybate on sleep quality, sleep architecture and measures of disrupted nighttime sleep in narcolepsy. Oxybate is the active ingredient in Xywav®…
PR Newswire
11/09/2023

Major shareholder announcement - BlackRock, Inc.

ANNOUNCEMENT NO. 24111 September 2023Major shareholder announcementMajor shareholder announcement–BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec A/S that BlackRock Investment Management (UK) Limited on September 7, 2023, has increased its total holdings and voting rights attached to shares and voting rights in ChemoMetec A/S to above 5% and thus exceeds the 5% limit in...
Nasdaq GlobeNewswire
11/09/2023

Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop…

Collaboration combines leading technologies to develop breakthrough, mRNA-enabledin vivoexpressed TCER® moleculesCompanies to leverage Immatics' XPRESIDENT® target discovery platform and Moderna's mRNA technology for the development of novel cancer vaccinesCollaboration to include evaluation of Immatics' investigational IMA203 PRAME TCR-T in combination with Moderna's investigational PRAME mRNA cancer vaccineImmatics to receive $120 million upfront cash payment plus research funding...
Nasdaq GlobeNewswire
11/09/2023

Healthcare logistics: Walden Group starts new nationwide GDP transport network…

"Eurotranspharma Deutschland will benefit from both Walden Group expertise as the leading player for example in the English, French, Belgian and Dutch markets, and from local expertise thanks to our four German shareholders and Mr. Segelke," declares Stéphane Baudry, Chairman of the Walden Group. He expects the network to start in early Q1 2024. "The fleet will consist of dual-temperature vans & trucks able to transport goods in both temperature ranges needed by the…
PR Newswire
11/09/2023
Altri  Comunicati